Glutamate metabolism in major depressive disorder

American Journal of Psychiatry

Volumn 171, Issue 12, 2014, Pages 1320-1327

  Abdallah, Chadi G ^a   Jiang, Lihong ^a   De Feyter, Henk M ^a   Fasula, Madonna ^a   Krystal, John H ^a   Rothman, Douglas L ^a   Mason, Graeme F ^a   Sanacora, Gerard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CARBON; GLUTAMIC ACID; PROTON;

ADULT; AGED; BIOLOGICAL MODEL; CITRIC ACID CYCLE; DIAGNOSTIC USE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; MITOCHONDRION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL LOBE; PROCEDURES; YOUNG ADULT;

ADULT; AGED; CARBON ISOTOPES; CITRIC ACID CYCLE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA; MODELS, BIOLOGICAL; NEUROIMAGING; OCCIPITAL LOBE; PROTONS; YOUNG ADULT;

EID: 84914127539     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2014.14010067     Document Type: Article

References (40)

1. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, DurkinM, Fairburn C, GlassRI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V, Sahakian BJ, Saxena S, Singer PA, Stein DJ; Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health: Grand challenges in global mental health. Nature 2011; 475:27-30.
2. Popoli M, Yan Z, McEwen BS, Sanacora G: The stressed synapse: The impact of stress and gluco corticoids on glutamate transmission. Nat Rev Neurosci 2012; 13:22-37.
3. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M, Chen G: Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012; 13:293-307.
4. Luykx JJ, Laban KG, van den Heuvel MP, Boks MP, Mandl RC, Kahn RS, Bakker SC: Region and state specific glutamate down regulation in major depressive disorder: A meta-analysis of (1)HMRS findings. Neurosci Biobehav Rev 2012; 36:198-205.
5. Krystal JH, Sanacora G, Duman RS: Rapid-acting glutamatergic antidepressants: The path to ketamine and beyond. Biol Psychiatry 2013; 73:1133-1141.
6. Luscher B, Shen Q, Sahir N: The GABA ergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011; 16:383- 406.
7. Petty F: GABA and mood disorders: A brief review and hypothesis. J Affect Disord 1995; 34:275-281.
8. Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ: Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry 2009; 65:792-800.
9. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF: Subtype-specific alterations of gammaamino butyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004; 61:705-713.
10. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ: Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 2010; 67:458-464.
11. Hasler G, Northoff G: Discovering imaging endophenotypes for major depression. Mol Psychiatry 2011; 16:604-619.
12. O'Shea RD: Roles and regulation of glutamate transporters in the central nervous system. Clin Exp Pharmacol Physiol 2002; 29:1018-1023.
13. Conti F, Minelli A, Melone M: GABA transporters in the mammalian cerebral cortex: localization, development, and pathological implications. Brain Res Brain Res Rev 2004; 45:196-212.
14. Rothman DL, De Feyter HM, de Graaf RA, Mason GF, Behar KL: 13C MRS studies of neuro energetics and neurotransmitter cycling in humans. NMR Biomed 2011; 24:943-957.
15. Rajkowska G, Stockmeier CA: Astro cyte pathology in major depressive disorder: Insights from human postmortem brain tissue. Curr Drug Targets 2013; 14:1225-1236.
16. Sanacora G, Banasr M: From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013; 73:1172-1179.
17. Hyder F, Rothman DL, Bennett MR: Cortical energy demands of signaling and non signaling components in brain are conserved across mammalian species and activity levels. Proc Natl Acad Sci USA 2013; 110:3549-3554.
18. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679.
19. Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, Krystal JH, Sanacora G: The antidepressant effect of keta mine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res 2011; 191:122-127.
20. Mason GF, Rothman DL: Graded image segmentation of brain tissue in the presence of inhomogeneous radio frequency fields. Magn Reson Imaging 2002; 20:431-436.
21. Petroff OA, Spencer DD, Alger JR, Prichard JW: High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989; 39:1197-1202.
22. Boumezbeur F, Mason GF, de Graaf RA, Behar KL, Cline GW, Shulman GI, Rothman DL, Petersen KF: Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J Cereb Blood Flow Metab 2010; 30:211-221.
23. Mason GF, Rothman DL: Basic principles of metabolic modeling of NMR (13)C isotopic turnover to determine rates of brain metabolism in vivo. Metab Eng 2004; 6:75-84.
24. Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shulman GI, Prichard JW, Shulman RG: Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neuro chem 1994; 63:1377-1385.
25. Mason GF, Falk Petersen K, de Graaf RA, Kanamatsu T, Otsuki T, Shulman GI, Rothman DL: A comparison of (13)C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-(13)C]glucose. Brain Res Brain Res Protoc 2003; 10:181-190.
26. Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL: The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo. Proc Natl Acad Sci USA 2005; 102:5588-5593.
27. Shen J, Rothman DL, Behar KL, Xu S: Determination of the glutamate-glutamine cycling flux using two-compartment dynamic metabolic modeling is sensitive to astroglial dilution. J Cereb Blood Flow Metab 2009; 29:108-118.
28. Chowdhury GM, Behar KL, Cho W, Thomas MA, Rothman DL, Sanacora G: 1H-[13C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolism. Biol Psychiatry 2012; 71:1022-1025.
29. Duarte JM, Gruetter R: Glutamatergic and GABA ergic energy metabolism measured in the rat brain by (13)C NMR spectroscopy at 14.1 T. J Neuro chem 2013; 126:579-590.
30. Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF: Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: A phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry 1997; 154:116-118.
31. Renshaw PF, Parow AM, Hirashima F, Ke Y, Moore CM, Frederick B deB, Fava M, Hennen J, Cohen BM: Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. Am J Psychiatry 2001; 158:2048-2055.
32. Drevets WC: Functional neuro imaging studies of depression: The anatomy of melancholia. Annu Rev Med 1998; 49:341-361.
33. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G: Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic, and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 2010; 15:501-511.
34. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, Mathew SJ: Increased ventricular lactate in chronic fatigue syndrome, III: relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder patho physiology. NMR Biomed 2012; 25:1073- 1087.
35. Yuen EY, Wei J, Liu W, Zhong P, Li X, Yan Z: Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 2012; 73: 962-977.
36. Martin JL, Magistretti PJ, Allaman I: Regulation of neurotrophic factors and energy metabolism by antidepressants in astro cytes. Curr Drug Targets 2013; 14:1308-1321.
37. Xiang Y, Shen J: Simultaneous detection of cerebral metabolism of different substrates by in vivo 13C isotopomer MRS. J Neurosci Methods 2011; 198:8-15.
38. Keedwell PA, Drapier D, Surguladze S, Giampietro V, Brammer M, Phillips M: Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. J Affect Disord 2010; 120:120-125.
39. Shaw A, Brealy J, Richardson H, Muthukumaraswamy SD, Edden RA, Evans CJ, Puts NA, Singh KD, Keedwell PA: Marked reductions in visual evoked responses but not g-aminobutyric acid concentrations or g-band measures in remitted depression. Biol Psychiatry 2013; 73:691-698.
40. Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA Jr: Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. JAMA Psychiatry 2013; 70:280-290.